+695.6%
CVNA vs THC
+253.4%
+442.1%
-53.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | -2.3% | +2.4% | +1.0% |
| 7D | +3.5% | -2.6% | +6.1% | +4.5% |
| 30D | +5.5% | -1.2% | +6.6% | +5.6% |
| 3M | +7.6% | +58.9% | -51.3% | -12.3% |
| 6M | +17.6% | +9.3% | +8.3% | +12.3% |
| YTD | -11.5% | +30.4% | -41.8% | -23.0% |
| 1Y | +0.4% | +34.6% | -34.2% | -15.5% |
| 3Y | +695.6% | +246.7% | +448.9% | +168.5% |
| All | +695.6% | +253.4% | +442.1% | +168.5% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling